TL;DR
This study analyzed 15 years of renal biopsy data from a major Chinese hospital, revealing a significant shift in the landscape of glomerular diseases. Contrary to previous trends, IgA nephropathy (IgAN) is no longer steadily increasing, while membranous nephropathy (MN) has emerged as the second most common primary glomerulonephritis, particularly in older age groups.
What Problem Does This Paper Address?
Accurate diagnosis of kidney diseases is crucial for effective treatment and prognosis. Renal biopsies are the gold standard for this, and understanding the trends in diagnosed kidney diseases over time is vital for public health planning and research. Previous studies, both internationally and within China, have indicated a consistent rise in IgA nephropathy (IgAN) as the most prevalent primary glomerulonephritis (PGN). However, there was a need to investigate if this trend continued and if other PGNs were also changing in prevalence, especially in a large, rapidly developing country like China. This paper addresses this by examining a 15-year period of renal biopsy data to identify shifts in the diagnostic landscape of glomerular diseases.
Methods
The researchers conducted a retrospective analysis of renal biopsy records from patients aged 15 and older at the First Affiliated Hospital of Zhejiang University between 2001 and 2015. They excluded patients with incomplete records, inadequate biopsies, or repeated biopsies, ultimately analyzing 10,779 cases. The data collected included the date of biopsy, age, sex, pathological type, and diagnosis.
For analysis, the data was divided into three 5-year intervals (2001-2005, 2006-2010, 2011-2015) and six age groups (15-24, 25-34, 35-44, 45-54, 55-64, and ≥65 years). Biopsies were categorized into primary glomerulonephritis (PGN) and secondary glomerulonephritis (SGN), with specific PGNs including IgAN, MN, mesangial progressive glomerulonephritis (MsPGN), minimal change disease (MCD), and focal segmental glomerulosclerosis (FSGS). SGNs included lupus nephritis (LN), Henoch-Schonlein nephritis (HSN), diabetic nephropathy (DN), and others. Statistical analysis involved Pearson's chi-square tests and Bonferroni correction for multiple comparisons.
Datasets
The study utilized a dataset of 10,779 renal biopsy records from the First Affiliated Hospital, Zhejiang University, collected between January 2001 and December 2015. This represents a single-center dataset. No new benchmarks were introduced.
Key Insights and Ideas
- IgAN Plateau: The long-standing trend of increasing IgA nephropathy (IgAN) appears to be halting or even reversing in East China. This is a significant departure from previous observations and suggests potential changes in environmental factors, lifestyle, or diagnostic practices.
- Membranous Nephropathy's Rise: Membranous nephropathy (MN) has shown a consistent and significant increase, becoming the second most common PGN. This rise is particularly notable in older age groups, hinting at potential links to aging, environmental exposures (like heavy metals or pollution), or other age-related factors.
- Shifting Age Demographics: The proportion of patients undergoing renal biopsies has shifted towards older age groups (over 45), likely due to an aging population and improved biopsy safety for elderly patients.
- Sex Differences Persist: Distinct sex predilections for certain diseases remain, with IgAN showing a female predominance and MN, FSGS, and MCD showing a male predominance. For SGNs, LN is more prevalent in females, while DN, BANS, and SV show male predominance in older age groups.
- MsPGN Decline: Mesangial progressive glomerulonephritis (MsPGN) has seen a decrease, possibly due to improved diagnostic criteria and classification, with cases now being more accurately categorized into other specific PGNs.
Key Results
- Overall Biopsy Increase: The number of renal biopsies performed annually increased dramatically over the 15-year period, from under 50 in 2001 to over 1000 in the last 5 years.
- PGN vs. SGN Trends: While PGN remained the most common category (78.8%), its proportion slightly decreased over time. Conversely, SGN increased from 14.2% to 20.1%.
- IgAN Dominance: IgAN was the most frequent PGN, accounting for 50% of cases. However, its trend showed a decrease in the most recent 5-year period.
- MN's Ascent: MN accounted for 16.8% of PGNs and showed a significant increase, becoming the second most common PGN.
- Age Distribution Shift: Patients under 45 years old showed a declining biopsy rate, while those over 45 showed a significant increase.
- SGN Landscape: Lupus nephritis (LN) was the most common SGN (29.2%), followed by Henoch-Schonlein nephritis (HSN) (19.2%) and diabetic nephropathy (DN) (9.9%). LN showed a modest decline after 2008, while DN increased significantly.
Limitations and Future Work
- Single-Center Study: The findings are from one referral center and may not be fully representative of the entire Chinese population. This could lead to a detection bias, especially as the hospital receives many severely ill patients.
- Observational Nature: The study is observational, meaning it can identify changes but cannot definitively explain the underlying causes.
- Biopsy Indications: The study reflects only those who underwent a biopsy, not the general population. The specific indications for biopsy might also influence the observed trends.
- Future Directions: The authors suggest that long-term observation is needed to confirm the trend of declining IgAN. Further studies are required to elucidate the roles of environmental factors, patient-specific factors, social development, and geographic regions in shaping these observed changes in kidney disease frequencies. Investigating the specific mechanisms behind the rise in MN, potentially linked to pollution or heavy metal exposure, is also a crucial area for future research.
Summary updated